Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence for cross-talk between stanniocalcins.

Mark Paciga1, Kathi James, J Ryan J Gillespie

  • 1Department of Physiology and Pharmacology, Faculty of Medicine and Dentistry, The University of Western Ontario, London, Canada.

Canadian Journal of Physiology and Pharmacology
|January 5, 2006
PubMed
Summary

Two forms of stanniocalcin (STC), STC50 and big STC, may functionally antagonize each other. STC50 can block big STC

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-Derived Factors with the Potential to Contribute to the Pathogenicity of HIV-1 and HIV-2: Roles of M-CSF and CXCL7.

International journal of molecular sciences·2025
Same author

Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1.

Viruses·2023
Same author

FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.

The oncologist·2017
Same author

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017
Same author

Cyclooxygenase-2 mediates induction of the renal stanniocalcin-1 gene by arginine vasopressin.

Molecular and cellular endocrinology·2013
Same author

Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.

Retrovirology·2012

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Reproductive Biology

Background:

  • The STC-1 gene produces two stanniocalcin (STC) forms: STC50 and big STC.
  • These forms exhibit distinct tissue expression and intracellular targeting.
  • STC50 targets mitochondria in tissues like muscle, liver, and kidney.
  • Big STC is produced by ovaries, signaling locally and systemically.

Purpose of the Study:

  • To investigate potential cross-talk and functional antagonism between STC50 and big STC.
  • To determine if STC50 can compete for big STC receptors.
  • To assess the effect of STC50 on big STC's inhibition of progesterone release.

Main Methods:

  • Receptor binding assays using STC50 as a tracer.
  • Experiments involving simultaneous addition of STC50 and big STC to luteal cells.

Related Experiment Videos

  • Measurement of luteal cell progesterone release.

    • Main Results:

    • STC50 demonstrated competition for tissue receptors typically targeted by big STC.
    • STC50 completely blocked the inhibitory effects of big STC on progesterone release when added concurrently.
    • Evidence suggests functional antagonism between STC50 and big STC.

    Conclusions:

    • The findings support the hypothesis of ligand cross-talk between STC50 and big STC.
    • STC50 and big STC may functionally antagonize each other under certain physiological conditions.
    • This antagonism could involve competition for shared tissue receptors.